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Abstract
Background: Obstructive sleep apnea (OSA) is common in obese patients with type 2 diabetes mellitus (DM) and may
contribute to diabetic microvascular complications.
Methods: To investigate the association between OSA, hypoxemia during sleep, and diabetic retinal complications in severe
obesity. This was a prospective observational study of 93 obese patients mean (SD) age: 52(10) years; mean (SD) body mass
index (BMI): 47.3(8.3) kg/m2) with DM undergoing retinal screening and respiratory monitoring during sleep. OSA was
defined as apnea-hypopnea index (AHI) of $15 events/hour, resulting in two groups (OSA+ vs. OSA2).
Results: Forty-six patients were OSA+: median (95% CI) AHI = 37(23–74)/hour and 47 were OSA–ve (AHI = 7(4–11)/hour).
Both groups were similar for ethnicity, BMI, cardiovascular co-morbidities, diabetes duration, HbA1c, and insulin treatment
(p.0.05). The OSA+ group was significantly more hypoxemic. There was no significant difference between OSA+ and OSA2
groups for the presence of retinopathy (39% vs. 38%). More OSA+ subjects had maculopathy (22% vs. 13%), but this did not
reach statistical significance. Logistic regression analyses showed that AHI was not significantly associated with the
presence of retinopathy or maculopathy (p.0.05). Whilst minimum oxygen saturation was not significantly associated with
retinopathy, it was an independent predictor for the presence of maculopathy OR= 0.79 (95% CI: 0.65–0.95; p,0.05), after
adjustment.
Conclusions: The presence of OSA, as determined by AHI, was not associated with diabetic retinal complications. In
contrast, severity of hypoxemia during sleep (minimum oxygen saturations) may be an important factor. The importance of
hypoxia in the development of retinal complications in patients with OSA remains unclear and further studies assessing the
pathogenesis of hypoxemia in patients with OSA and diabetic retinal disease are warranted.
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Introduction
Obstructive sleep apnea (OSA) is characterized by frequent
partial or complete cessation of breathing during sleep leading
to intermittent low oxygen levels in the blood (hypoxemia) with
subsequent low oxygen levels in organs and tissues (hypoxia) [1].
OSA is common, affecting an estimated one in five middle-aged
men [2]. The prevalence of OSA rises with increasing adiposity
[2] and it is estimated that up to 75% of those with a body
mass index (BMI) above 40 kg/m2 (extreme obesity) have OSA
[3]. With the increasing prevalence of obesity, sleep clinics are
more frequently serving severely obese patients with OSA and
diabetes mellitus. OSA has been reported to be associated with
insulin resistance, metabolic syndrome, type 2 diabetes mellitus
(DM) and vascular disease [4–7]. Moderate to severe OSA has
been associated with an increased risk of DM [8]. The reported
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prevalence of OSA in patients with DM ranges from 23 to 86%
[7,9].
Frequent episodes of hypoxemia during sleep in OSA have been
reported to be associated with raised inflammatory mediators [10].
In DM, inflammatory mediators are also elevated [11], and are
contributory to diabetic micro-vascular complications such as
diabetic retinal disease (diabetic retinopathy (DR) and diabetic
maculopathy (DMac)), a leading cause of blindness [12]. Some
studies have shown that concomitant OSA in DM patients might
be associated with significantly more DR cases, and more
advanced sight-threatening DMac, with the suggestion that OSA
is an independent risk factor for diabetic retinal complications
[13,14]. These studies used oxygenation as part of their definition
of OSA, suggesting that the intermittent hypoxemia and re-
oxygenation episodes in OSA lead to a greater oxidative stress and
inflammatory responses, and hence worsening of diabetic retinal
disease [15]. There is very little information, however, regarding
the association between sleep-disordered breathing as defined by
apnea-hypopnea frequency and diabetic retinal complications, or
whether other hypoxemia parameters are important, particularly
the degree of hypoxemia during sleep (e.g. minimum oxygen
saturations or time spent under 90% oxygen saturations).
Furthermore, little has been studied in patients with severe
obesity, a high-risk group for OSA and DM. We hypothesized that
DM patients with severe obesity and moderate-to-severe OSA (as
defined by apnea – hypopnea frequency) will have a higher
prevalence of diabetic retinal disease compared to those without
OSA. We therefore undertook a cross-sectional evaluation of a
cohort of consecutive severe obese patients with DM undergoing
assessment with routine clinical retinal screening and overnight
respiratory sleep monitoring.
Materials and Methods
Study Design and Study Subjects
A cohort of consecutive patients attending the regional specialist
weight management service at Birmingham Heartlands Hospital,
UK between 2009 and 2011 was studied. Routine clinical data
collected included age, gender, self-reported ethnicity, weight,
BMI, cardiovascular co-morbidities (hypertension and coronary
artery disease), duration of DM, DM medications, HbA1c (DCCT-
aligned and IFCC), and renal function (creatinine and estimated
glomerular filtration rate (eGFR)).
Respiratory Sleep Monitoring Methods
Patients underwent home portable respiratory monitoring
during sleep using the EmblettaTM (Embla systems). The protocol
for this system is used as part of standard clinical care in the
current service setting. All patients were shown how to utilize the
equipment by a trained physiologist in sleep medicine on the
afternoon of the test night. Measurement channels included
airflow using a nasal pressure device, chest and abdominal
movements by inductance plethysmography, oxygen saturation
through pulse oximetry, heart rate, and body position. The staff
observed the patient undergoing a trial of self-application before
leaving the sleep physiology department. Devices were returned
the next day and studies were downloaded and reviewed for data
quality. Patient filled in a sleep diary for the night of time to bed
and time to estimated sleep and time wake up to assess the
matching with the objective sleep respiratory signals. Studies
showing at least four hours of good quality respiratory signals were
regarded as acceptable. If any data were deemed inadequate, the
patient was offered a retest. All data were manually scored by
blinded sleep trained physiologists and then rescored by author
DB for confirmation. Author DB was blinded to any diabetic eye
screening data. All parameters were scored based on respiratory
event during sleep scoring guidelines published by the American
Academy of Sleep Medicine [16]. Respiratory parameter data
collected included: apnea/hypopnea index (AHI), mean and
minimum oxygen saturation during sleep, and the percentage of
time spent under 90% oxygen saturation while asleep. OSA in this
study was defined as the presence of an AHI greater or equal
($)15/hour (OSA+). Those with AHI of less than 15/hour were
regarded as the OSA– group. The AHI was used as the diagnostic
parameter for OSA and not the oxygen desaturation index (4%) or
ODI. ODI was not measured in this study. The cut-off point for
AHI of 15/hour was selected as it forms part of the clinical
decision making determining whether or not to treat with
continuous positive airway pressure (CPAP).
Retinal Screening Methods
DR data were obtained from the routine local screening
program based on the English National Screening Program for
Diabetic retinopathy (ENSPDR). Two 45u fields per eye (1 fovea-
centered, 1 disc-centered) are obtained on an annual basis.
ENSPDR has developed guidance on the classification of the
severity of diabetic retinopathy in England and Wales [17]. All
diabetes patients attending the clinic underwent annual retinal
screening and data were acquired from the most recent screening
assessment. Presence or absence of DR and DMac were recorded.
DMac is defined as any evidence of exudate, microaneurysm or
haemorrhage with 1 disc diameter of the center of fovea [17].
Statistical Analysis
All statistical analyses were carried out using the Statistical
Package for Social Sciences, version 19 (SPSS, Chicago, IL). Data
analysis was performed on anonymized patients as part of service
evaluation, therefore no formal ethical approval was required as
per recommendation from the UK National Research Ethics
Service [18]. Normally distributed data are reported as mean 6
standard deviation (SD) and analyzed using an independent t-test
whilst skewed data are reported as median and interquartile range
(IQR) and the Mann Whitney U-test was used for analysis.
Categorical data were analyzed using the chi-squared test.
Univariate analyses were carried out to examine factors associated
with diabetic retinal disease. Logistic regression analyses were
conducted and three models constructed to examine associations
between 1) AHI (continuous); 2) mean oxygen saturation; 3)
minimum oxygen saturation (min O2); and 4) % time spent under
90% oxygen saturation; and DR as well as DMac. Model 1 was
unadjusted, Model 2 adjusted for age, gender and ethnicity, and
Model 3 was further adjusted for DM duration, insulin treatment
and HbA1c, hypertension, and coronary artery disease. Results
were reported as odds ratio (OR) with 95% confidence interval
(95% CI). A p value of ,0.05 was considered statistically
significant.
Results
There were a total of 121 DM patients eligible, but three
patients’ sleep respiratory data were not analyzable, and 26
patients did not have the complete available retinopathy screening
data; therefore, a total of 93 eligible patients were included in the
study. No patient had a diagnosis of central sleep apnea.
The mean (SD) age of the patients was 52(10) years and 59% of
the patients were females. The majority of patients were of white
European origin (69%) and 23% were of South Asian origin.
Mean (SD) weight and BMI were 130.4(25.3) Kg and 47.3(8.3)
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Kg/m2, respectively. Sixty-three per cent of patients suffered from
hypertension. Median (IQR) duration for DM was 6(2–10) years
with a median (IQR) HbA1c of 62(51–77) mmol/mol or 7.8(6.8–
9.2)%. The majority of patients were on diabetes medications
(81.7%) and 33% of the patients were on insulin treatment.
Median (IQR) AHI was 14(7–36) events/hour with a median
(IQR) minimum oxygen saturation 82(74–85)% and median (IQR)
% time spent under 90% oxygen saturation of 3(1–12)% for the
total sample.
Table 1 shows the patient characteristics, according to the
presence or absence of OSA, determined by AHI. Of the 93
patients, 46(51%) had an AHI$15 events/hour with a median
(IQR) AHI of 37(23–74)/hour (OSA+), compared to those with an
AHI ,15/hour; median (IQR) AHI=7(4–11)/hour (OSA2).
Both OSA+ and OSA2 groups were well matched for ethnicity,
weight, BMI, co-morbidities, diabetes duration, HbA1c and DM
medication (p.0.05). The OSA+ group were slightly older than
those without OSA (54(10) vs. 49(10) years, p = 0.01) with a greater
proportion of males (66% vs. 25%, p= 0.002).
Table 2 shows the retinal screening results. The overall
prevalence of DR and DMac were present in 38.7% and 17.2%,
respectively. No significant differences were found between the
presence/absence of OSA for DR (39% vs. 38%, p= 0.765).
However more OSA+ patients had DMac compared to OSA2
patients (22% vs. 13%), but this did not reach statistical
significance (p= 0.252).
Univariate logistic regression identified factors significantly
associated with diabetic retinal disease. Diabetic retinal disease
was significantly associated with diabetes duration (OR 1.12; 95%
CI: 1.04–1.21) and insulin treatment (OR 8.21; 95% CI: 3.08–
21.83). DMac was associated with HbA1c (OR1.48; 95% CI: 1.06–
2.06), DM duration (OR 1.16; 95% CI: 1.06–1.26), insulin
treatment (OR24.29; 95% CI: 5.02–117.57) and hypertension
(OR4.98; 95% CI: 1.06–23.44). The results of our multivariate
logistic regression analyses are shown in Table 3. We observed,
after adjustment, no relationship between DR and AHI, mean
oxygen saturation, minimum oxygen saturation, and % time spent
,90% oxygen saturation. After adjustment, the presence of DMac
was not associated with AHI, mean oxygen saturation, and % time
spent ,90% oxygen saturation. Minimum oxygen saturation was,
however, after adjustment, an independent and significant
predictor for the presence of DMac OR=0.79 (95% CI: 0.65–
0.95; p,0.05)).
Discussion
Retinal disease is a well-recognized micro-vascular complication
of DM [19]. To our knowledge, this is the first DR prevalence
study on extreme obese individuals. Our study shows that the
overall prevalence of DR amongst extreme obese DM patients was
38.7%. This is slightly higher than the reported global DR
prevalence of 34.6% despite our patients being 6 years younger
and having shorter DM duration (6.0 vs. 7.9 years) compared to
the study by Yau et al [20]. A study on the National Health and
Nutrition Examination Survey study from 2005 to 2008 reported
an even lower estimated DR prevalence of 28% [21]. The
discrepancy may be due to the fact that our study only has severely
obese DM patients, who are an increasingly important at-risk
group.
Our study did not show any significant difference in the
prevalence of diabetic retinal disease between those who had
moderate to severe OSA compared to those who did not. We
examined the relationship between diabetic retinal disease and
respiratory parameters using logistic regression analysis. After
correction for age, gender, ethnicity, diabetes duration, usage of
insulin and the presence of hypertension, there was no association
found between mean oxygen saturations, and % time spent under
90% oxygen saturations and retinal disease. Our results were
consistent with the Japanese studies, which did not find any
correlation with the above respiratory parameters [14,15].
There has been much interest in the role of OSA in the
development of micro-vascular complications in patients with DM;
this study showed that OSA, when measured by using the apnea –
Table 1. Sample characteristics of 93 patients according to
presence/absence of obstructive sleep apnea.
OSA2
(n = 47)
OSA+
(n = 46) p value
Age (years) 49610 54610 0.010
Gender, n (%) 0.002
Female, 55 (59) 35 (75) 20 (43.5)
Ethnicity, n (%) 0.716
White European 34 (72) 30 (65)
South Asian 9 (19) 12 (26)
Afro-Carribean 4 (9) 4 (9)
Weight (kg) 127623 135627 0.142
BMI (kg/m2) 47.168.1 47.668.5 0.776
Systolic BP (mmHg) 139615 146623 0.177
Diastolic BP (mmHg) 83610 85612 0.446
Co-morbidities, n (%)
Hypertension 26 (55) 33 (72) 0.100
CAD 5 (11) 7 (15) 0.510
Diabetes parameters
DM duration (years) 6 (3–11) 6 (2–10) 0.423
DM medications, n (%) 0.795
None 9 (19) 8 (17)
One 10 (21) 14 (30)
Two 20 (43) 17 (37)
Three or more 8 (17) 7 (15)
HbA1c (%) 7.7 (6.7–9.3) 8.1 (7.1–9.2) 0.267
Insulin treatment 12 (26) 19 (41) 0.123
Respiratory parameters
AHI (/hour) 7 (4–11) 37 (23–74) ,0.001
Mean O2 saturation (%) 94 (92–95) 93 (91–94) 0.001
Minimum O2 saturation (%) 84 (82–88) 76 (71–82) ,0.001
% Time spent ,90% saturation 1 (0–3) 11 (2–25) ,0.001
Renal parameters
Creatinine 67 (57–79) 78 (66–93) 0.002
eGFR (ml/min/1.73 m2) 90 (77–90) 83 (61–90) 0.068
Retinopathy outcome, n (%)
Retinopathy present 18 (38) 18 (39) 0.934
Maculopathy present 6 (13) 10 (22) 0.252
Data are presented as mean6standard deviation, number (%), or median
(interquartile range).
OSA= obstructive sleep apnea; BMI = body mass index; CAD= coronary artery
disease; DM=diabetes mellitus; BP = blood pressure; eGFR= estimated
glomerular filtration rate.
p values were calculated using either independent t-test, chi square or Mann
Whitney U-test.
doi:10.1371/journal.pone.0079521.t001
Sleep Apnea and Retinopathy
PLOS ONE | www.plosone.org 3 November 2013 | Volume 8 | Issue 11 | e79521
hypopnea index, has no association with retinal complications.
Only one study investigated the effect of AHI and DR and it was
performed in 98 veterans who are predominantly male. Although
this study found a significant positive correlation between DR and
AHI, the result was not adjusted for potential confounders [22].
The patients were also much older (9 years older) with more severe
OSA (mean AHI 31 events/hr) compared to our study [22]. Other
studies have found a positive association between ODI and DR
[13,14]. Shiba and colleagues compared 116 proliferative (PDR)
and 48 non-proliferative DR (NPDR) inpatients [14]. They
reported a 43% correlation between ODI and PDR [14]. Our
study was not designed to investigate PDR and OSA as we only
have 4 episodes of PDR in our study. The other study from
Oxford investigated 118 males and found significant correlation
Table 2. Diabetic retinopathy in 93 patients according to presence/absence of obstructive sleep apnea.
OSA2 (n = 47) n (%) OSA+ (n = 46) n (%) p value
Both eyes
No retinopathy 29 (61.7) 28 (60.9) 0.765
Background retinopathy 15 (31.9) 13 (28.3)
Pre-proliferative retinopathy 1 (2.1) 3 (6.5)
Proliferative retinopathy 2 (4.3) 2 (4.3)
Maculopathy 6 (12.8) 10 (21.7) 0.252
Photocoagulation 3 (6.4) 2 (4.3) 0.664
Right eye
No retinopathy 32 (68.1) 30 (65.2) 0.943
Background retinopathy 12 (25.5) 12 (26.1)
Pre-proliferative retinopathy 2 (4.3) 2 (4.3)
Proliferative retinopathy 1 (2.1) 2 (4.3)
Maculopathy 5 (10.6) 5 (10.9) 0.971
Photocoagulation 3 (6.4) 2 (4.3) 0.664
Left eye
No retinopathy 33 (70.2) 31 (67.4) 0.777
Background retinopathy 11 (23.4) 10 (21.7)
Pre-proliferative retinopathy 1 (2.1) 3 (6.5)
Proliferative retinopathy 2 (4.3) 2 (4.3)
Maculopathy 5 (10.6) 10 (21.7) 0.146
Photocoagulation 3 (6.4) 2 (4.3) 0.664
OSA= obstructive sleep apnea.
p values derived from chi square test.
doi:10.1371/journal.pone.0079521.t002
Table 3. Logistic regression analyses assessing the presence of diabetic retinopathy (DR) and maculopathy (DMac) with four
respiratory parameters.
Presence of retinopathy (DR) Model 1 Model 2 Model 3
AHI 1.01 (0.99–1.02) 1.01 (0.99–1.02) 1.00 (0.98–1.02)
Mean oxygen saturation 0.89 (0.77–1.03) 0.90 (0.77–1.05) 0.83 (0.67–1.02)
Minimum oxygen saturation 0.95* (0.90–1.00) 0.95 (0.89–1.00) 0.93 (0.86–1.01)
Time spent ,90% oxygen saturation 1.03 (1.00–1.05) 1.03 (1.00–1.06) 1.03 (1.00–1.06)
Presence of maculopathy (DMac) Model 1 Model 2 Model 3
AHI 1.01 (1.00–1.03) 1.01 (0.99–1.03) 1.01 (0.98–1.04)
Mean oxygen saturation 0.93 (0.79–1.08) 0.92 (0.77–1.09) 0.80 (0.59–1.07)
Minimum oxygen saturation 0.91** (0.85–0.97) 0.90** (0.84–0.97) 0.79* (0.65–0.95)
% Time spent ,90% oxygen saturation 1.02 (0.99–1.04) 1.02 (0.99–1.04) 1.03 (0.99–1.08)
Model 1: unadjusted.
Model 2: adjusted for age, gender, ethnicity.
Model 3: further adjusted for diabetes mellitus duration, insulin treatment, HbA1c, hypertension, and coronary artery disease.
*p,0.05;
**p,0.01.
doi:10.1371/journal.pone.0079521.t003
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between ODI and HbA1c with DR [13]. However, this study is not
comparable to ours as it used ODI rather than AHI and the
patients had a much longer duration of DM (10 years) and were a
much older group (67 years) compared to our study [13].
Logistic regression analyses showed that the degree of hypox-
emia, determined by minimum oxygen saturation during sleep,
was associated with the development of DMac, but not DR. As the
OSA group was more hypoxemic than the group without
moderate to severe OSA, this may explain why the OSA+ had a
higher prevalence of DMac. The relationship between OSA and
diabetic retinal disease is important given the risk of blindness
[19]. West et al, in a study of 118 DM male patients, reported that
OSA (mean (SD) ODI 20.9(16.6) per hour vs. 2.8(2.1) per hour in
the control group) was associated with DMac (r2 = 0.3) [13]. In
another study by Shiba et al of 219 DM patients, it was found that,
after adjusting for potential confounders, the lowest oxygen
saturation and not ODI or % time spent under 90% oxygen
saturation significantly correlated with the development of
proliferative DR (OR=0.93, 95% CI0.88–0.99; p = 0.02) [15].
It is of note that the diagnosis of OSA for both the studies was
made on the basis of oxygenation (ODI) and not breathing
parameters (AHI) that the severity of obesity as measured by BMI
was significantly lower than our study.
The findings of our study show that minimum oxygen
saturation may be associated with DMac supports the findings
by Shiba et al [15]. Although our study measured AHI rather than
ODI, the combination of results from our and Shiba et al. [14]
studies on oxygenation and diabetic eye micro-vascular disease,
may indicate that intermittent hypoxemia and lowest oxygen
saturation (and not apnea/hypopnea frequency) is independently
associated with diabetic retinal disease especially DMac. The
animal [23] and human [24] studies have shown that chronic
intermittent hypoxia is linked to a reduction in endothelial
relaxation and greater vasoconstriction. This may impair oxygen-
ation to the retina leading to diabetic retinal disease, particularly in
vulnerable areas such as the macula. Apart from dysfunction in
vaso-reactivity, oxidative stress and systemic inflammation may
also play a part. The study by Yamauchi et al showed that ODI
was correlated to oxidative stress markers in subjects with OSA
[25]. Vascular endothelial growth factor (VEGF) has been found
to be elevated in hypoxic OSA patients [10] and may be associated
with the neovascularization process in ischemic retinal disease
[11]. Further longitudinal studies are required to examine the
causal effect of hypoxia from OSA on diabetic retinal disease.
Apart from intermittent hypoxia, the other potential mecha-
nisms for greater DMac in OSA patients may be due to elevated
BP and severity of DM. Hypertension is strongly associated with
OSA [5,26]. Although not statistically significant, systolic BP for
our OSA+ patients was higher compared to OSA2 (146 vs.
139 mmHg). It is well-recognized that BP plays an important role
in DR progression as shown in the UKPDS study [27]. Insulin use
is sometimes used as a surrogate marker for greater severity of DM
and has been found to have a significant impact on DR in
overweight T2D patients [28]. In our study, a greater proportion
in OSA+ group was treated with insulin (41% vs. 26%) compared
to OSA2 group. This is unsurprising as there is an association
between greater insulin resistance and impaired glucose metabo-
lism with severity of OSA [4,8]. HbA1c level was also 0.4% higher
in the OSA+ group and this is also associated with severe DR [29].
Our study also examined creatinine and eGFR levels. There
was a significant higher creatinine level and a non-significant lower
eGFR in OSA+ group. These findings may act as a reassurance in
the probable greater early development of diabetic retinal disease
as part of DM micro-vascular complications in our OSA+ group.
The impact of correcting OSA on micro-vascular complications
remains unknown but a study recently by Mason et al looking at
the impact of CPAP on patients with OSA (defined as ODI.10
events/hr or AHI.15 per hour) on macular edema showed no
improvement in the disease, but interestingly, some improvement
in visual acuity [30].
Our study benefits from well-matched groups that are
representative of the severely obese population and the ethnic
diversity of our local population. The OSA+ and OSA2 groups
were well matched for BMI, co-morbidities, diabetes duration, and
diabetes medications. The OSA+ group had more men and was
older than the OSA2 but these differences were accounted for
when undergoing statistical analyses. Also, in our analyses, we
observed the expected and previously reported factors associated
with diabetic retinal disease. The limitations of our study include
its cross-sectional design and lack of information regarding other
potentially important factors such as smoking. Visual acuity data
were also not available.
Conclusions
This study of severely obese patients with DM found no
association between OSA and DR but there was a higher
prevalence of DMac in those with moderate to severe OSA.
Further analysis suggests that the severity of hypoxemia, partic-
ularly minimum oxygen saturation has an independent association
with the development of maculopathy but the exact mechanism
for this remains unclear. As this OSA group was more hypoxemic,
it is hypothesized that hypoxemia and not apnea/hypopnea
frequency per se is the key factor in developing diabetic micro-
vascular complications. The other likely potential mechanisms
were greater systemic hypertension and severity of DM in OSA.
The impact of CPAP on micro-vascular retinal complications in
OSA patients remains undetermined, but further RCTs may be
warranted to specifically look at the hypoxemic OSA group.
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